SEROTONIN RECEPTOR SUBTYPES - FUNCTIONAL, PHYSIOLOGICAL, AND CLINICAL CORRELATES

被引：47

作者：

BONATE, PL ^{[1
]}

机构：

[1] WASHINGTON STATE UNIV,COLL PHARM,PROGRAM PHARMACOL TOXICOL,PULLMAN,WA 99164

来源：

CLINICAL NEUROPHARMACOLOGY | 1991年 / 14卷 / 01期

关键词：

SEROTONIN; 5-HYDROXYTRYPTAMINE; RECEPTOR;

D O I：

10.1097/00002826-199102000-00001

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The effects of 5-HT are varied and widely distributed throughout the human body. At this time, 5-HT research is a field ripe for ''plucking.'' Not only is there a great demand for more selective agonists and antagonists, but there is more than enough work needed in receptor binding studies to keep pharmacologists employed for years to come. The clinical benefits of 5-HT receptor pharmacology are just starting to be developed and explored. Novel treatments for hypertension, migraine headaches, anxiety, and depression using 5-HT are just the beginning. It will be exciting to see what the future holds for 5-HT clinically.

引用

页码：1 / 16

页数：16

共 102 条

[1] ADAMS RD, 1985, BARRISON PRINCIPLES, P126
[2] ANDRADE R, 1985, J NEUROSCI, V5, P2359
[3] 5-HT RECEPTORS IN THE CORONARY CIRCULATION
ANGUS, JA
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (03) : 89 - 90
[4] ASBERG M, 1976, SCIENCE, V191, P478
[5] ASHCROFT GW, 1966, LANCET, V2, P1049
[6] FLUOXETINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN DEPRESSIVE-ILLNESS
BENFIELD, P
HEEL, RC
LEWIS, SP
[J]. DRUGS, 1986, 32 (06) : 481 - 508
[7] BLACKSHEAR MA, 1982, J PHARMACOL EXP THER, V221, P303
[8] BLAU JN, 1987, MIGRAINE THERAPEUTIC
[9] SEROTONIN AND APPETITE
BLUNDELL, JE
[J]. NEUROPHARMACOLOGY, 1984, 23 : 1537 - 1551
[10] PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE
BRADLEY, PB
ENGEL, G
FENIUK, W
FOZARD, JR
HUMPHREY, PPA
MIDDLEMISS, DN
MYLECHARANE, EJ
RICHARDSON, BP
SAXENA, PR
[J]. NEUROPHARMACOLOGY, 1986, 25 (06) : 563 - 576

← 1 2 3 4 5 6 7 8 9 10 →